Biosimilars: Advantages & Challenges

Biosimilars: Advantages & Challenges

Introduction A biosimilar product, as defined by USFDA, is “a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product.” By 2020, the biosimilar market is expected to reach $15 billion...
INNOVATIONS IN PEER-REVIEW

INNOVATIONS IN PEER-REVIEW

Peer Review is the process of evaluation of manuscripts submitted for scientific publication in journals/books, pre-clinical or clinical study reports, research progress reports etc., by experts or peers with similar competence as manuscript authors. It plays a...
Significance of Publication Planning

Significance of Publication Planning

Publication planning is that part of the pharmaceutical landscape that ensures that data from pharma companies (clinical trials, commentaries on drug/device class, and other publications supporting the efficacy of drug/device) is disseminated through medical journal...
Loading...